SI0941738T1 - Antigenic conjugates of conserved lipooligosaccharides of gram negative bacteria - Google Patents
Antigenic conjugates of conserved lipooligosaccharides of gram negative bacteriaInfo
- Publication number
- SI0941738T1 SI0941738T1 SI9930797T SI9930797T SI0941738T1 SI 0941738 T1 SI0941738 T1 SI 0941738T1 SI 9930797 T SI9930797 T SI 9930797T SI 9930797 T SI9930797 T SI 9930797T SI 0941738 T1 SI0941738 T1 SI 0941738T1
- Authority
- SI
- Slovenia
- Prior art keywords
- negative bacteria
- gram negative
- conserved
- lipooligosaccharides
- lipopolysaccharide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3752998A | 1998-03-10 | 1998-03-10 | |
EP99301747A EP0941738B1 (fr) | 1998-03-10 | 1999-03-09 | Conjugués antigéniques de lipooligosaccharides de bactéries gram-négatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SI0941738T1 true SI0941738T1 (en) | 2005-10-31 |
Family
ID=21894823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9930797T SI0941738T1 (en) | 1998-03-10 | 1999-03-09 | Antigenic conjugates of conserved lipooligosaccharides of gram negative bacteria |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0941738B1 (fr) |
JP (1) | JPH11322793A (fr) |
KR (1) | KR100628664B1 (fr) |
AT (1) | ATE295181T1 (fr) |
AU (2) | AU766184B2 (fr) |
BR (1) | BR9902008A (fr) |
CA (1) | CA2264970A1 (fr) |
DE (1) | DE69925187T2 (fr) |
DK (1) | DK0941738T3 (fr) |
ES (1) | ES2241240T3 (fr) |
PT (1) | PT941738E (fr) |
SI (1) | SI0941738T1 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU782337B2 (en) * | 1999-09-30 | 2005-07-21 | Isis Innovation Limited | Vaccines against Neisseria infection |
AU2001253568A1 (en) | 2000-04-18 | 2001-10-30 | Dan C. Deborde | Lipopolysaccharide-conjugate vaccine for sepsis treatment |
US7749511B2 (en) | 2000-04-18 | 2010-07-06 | Endobiologics, Incorporated | Anti-sepsis conjugate vaccine |
ATE357461T1 (de) | 2000-08-25 | 2007-04-15 | Aventis Pasteur | Innen-kern oligosaccharide epitopes aus lipopolysacchariden von haemophilus influenza als vakzinen in der prophylaktischen behandlung von haemophilus influenzae infektionen |
US7527797B1 (en) * | 2000-09-01 | 2009-05-05 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Vibrio cholerae 0139 conjugate vaccines |
EP1374892A1 (fr) * | 2002-06-28 | 2004-01-02 | Braun, Jan Matthias, Dr. | Médicament pour le traitement des maladies causées par une infection de neisseria meningitidis |
JP2006506467A (ja) | 2002-08-02 | 2006-02-23 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン組成物 |
AU2003295520B8 (en) | 2002-11-12 | 2011-05-19 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for Staphylococcal infections |
PT2336147E (pt) | 2003-12-17 | 2014-07-16 | Janssen Alzheimer Immunotherap | Conjugados transportadores de péptidos beta imunogénicos e seus processos de produção |
WO2005058940A2 (fr) * | 2003-12-17 | 2005-06-30 | Wyeth | Conjugues porteurs de peptides immunogenes et procedes de production associes |
AU2005317304B2 (en) * | 2004-12-17 | 2011-06-23 | De Staat Der Nederlanden, Vert. Door De Minister Van Vws | Deacylation of LPS in Gram negative bacteria |
HUE031380T2 (en) | 2005-06-27 | 2017-07-28 | Glaxosmithkline Biologicals Sa | A method for producing vaccines |
TW200806315A (en) * | 2006-04-26 | 2008-02-01 | Wyeth Corp | Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
WO2007144316A2 (fr) | 2006-06-12 | 2007-12-21 | Glaxosmithkline Biologicals Sa | Vaccin |
RU2532911C2 (ru) | 2008-07-21 | 2014-11-20 | Дзе Брихэм Энд Уимен'З Хоспитал, Инк. | Способы и композиции, относящиеся к синтетическим бета-1,6-глюкозаминолигосахаридам |
EP2429658B1 (fr) | 2009-05-14 | 2016-04-20 | Sanofi Pasteur | Procédé pour adjuver le lipopolysaccharide (LPS) des bactéries à gram-négatif |
CA2761924C (fr) | 2009-05-14 | 2017-10-31 | Sanofi Pasteur | Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6 |
WO2010134225A1 (fr) * | 2009-05-20 | 2010-11-25 | 国立大学法人鳥取大学 | Procédé de détection d'une infection par une bactérie pathogène neisseria au moyen d'un épitope partiel de la chaîne de sucre et vaccin contre ladite bactérie |
JP2013521770A (ja) | 2010-03-10 | 2013-06-13 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン組成物 |
HUE048398T2 (hu) | 2010-06-04 | 2020-07-28 | Wyeth Llc | Vakcinakészítmények |
PL404229A1 (pl) | 2013-06-06 | 2014-12-08 | Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością | Wyizolowany immunogenny antygen bakteryjny i jego zastosowanie w profilaktyce i leczeniu zakażeń wywołanych przez Gram-ujemne bakterie |
CN103308686B (zh) * | 2013-06-28 | 2016-04-06 | 武汉云克隆科技股份有限公司 | 脂多糖酶联免疫吸附测定试剂盒的制备方法 |
KR101509456B1 (ko) * | 2013-10-04 | 2015-04-14 | 아이진 주식회사 | 리포폴리사카라이드 유사체 및 이를 포함하는 면역보조 조성물 |
CN104352762A (zh) * | 2014-12-11 | 2015-02-18 | 谭清平 | 一种用于治疗脓毒症的中药及其制备方法 |
SG11201901394XA (en) | 2016-09-02 | 2019-03-28 | Sanofi Pasteur Inc | Neisseria meningitidis vaccine |
WO2018096007A2 (fr) * | 2016-11-25 | 2018-05-31 | Glaxosmithkline Biologicals S.A. | Conjugués immunogènes et leur utilisation |
CN112125832B (zh) * | 2020-08-12 | 2022-09-20 | 北京大学 | 刺突蛋白受体结合结构域纳米凝胶及其制备方法与应用 |
KR20240004299A (ko) * | 2021-03-15 | 2024-01-11 | 그리피스 유니버시티 | 병원체 모이어티 및 이의 용도 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6887483B2 (en) * | 1995-12-01 | 2005-05-03 | University Of Iowa Research Foundation | Non-toxic mutants of pathogenic gram-negative bacteria |
-
1999
- 1999-03-08 CA CA002264970A patent/CA2264970A1/fr not_active Abandoned
- 1999-03-09 EP EP99301747A patent/EP0941738B1/fr not_active Revoked
- 1999-03-09 JP JP11061354A patent/JPH11322793A/ja active Pending
- 1999-03-09 KR KR1019990007668A patent/KR100628664B1/ko not_active IP Right Cessation
- 1999-03-09 BR BR9902008-4A patent/BR9902008A/pt not_active Application Discontinuation
- 1999-03-09 ES ES99301747T patent/ES2241240T3/es not_active Expired - Lifetime
- 1999-03-09 DE DE69925187T patent/DE69925187T2/de not_active Expired - Fee Related
- 1999-03-09 SI SI9930797T patent/SI0941738T1/xx unknown
- 1999-03-09 PT PT99301747T patent/PT941738E/pt unknown
- 1999-03-09 AU AU19540/99A patent/AU766184B2/en not_active Ceased
- 1999-03-09 DK DK99301747T patent/DK0941738T3/da active
- 1999-03-09 AT AT99301747T patent/ATE295181T1/de not_active IP Right Cessation
-
2004
- 2004-01-07 AU AU2004200060A patent/AU2004200060B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU2004200060A1 (en) | 2004-01-29 |
ATE295181T1 (de) | 2005-05-15 |
DK0941738T3 (da) | 2005-08-08 |
EP0941738A1 (fr) | 1999-09-15 |
DE69925187T2 (de) | 2006-03-09 |
JPH11322793A (ja) | 1999-11-24 |
DE69925187D1 (de) | 2005-06-16 |
KR100628664B1 (ko) | 2006-09-27 |
CA2264970A1 (fr) | 1999-09-10 |
AU766184B2 (en) | 2003-10-09 |
KR19990077705A (ko) | 1999-10-25 |
BR9902008A (pt) | 2000-05-09 |
AU2004200060B2 (en) | 2005-10-13 |
ES2241240T3 (es) | 2005-10-16 |
EP0941738B1 (fr) | 2005-05-11 |
PT941738E (pt) | 2005-09-30 |
AU1954099A (en) | 1999-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI0941738T1 (en) | Antigenic conjugates of conserved lipooligosaccharides of gram negative bacteria | |
DE3587342D1 (en) | Cyclosporine. | |
EP1028749A4 (fr) | Antigenes et vaccins tires d'enterococcus | |
WO1998058668A3 (fr) | VACCIN CONTENANT UN ANTIGENE DE $i(BORDETELLA PERTUSSIS) | |
AU3065489A (en) | T-cell epitope as carriers molecule for conjugate vaccines | |
HUP0103100A3 (en) | Immunogenic betha-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide | |
GB9928196D0 (en) | Combinations of B, C and other antigens | |
NO2006005I2 (no) | Difteri-,tetanus-, acellulære kikhoste- og polioantigener | |
NZ236050A (en) | Water soluble conjugate of a polymyxin and a carrier | |
WO2001049266A3 (fr) | Systeme de distribution de chelateur de fer | |
EP0694309A3 (fr) | Compositions vaccinales contenant des antigènes et des anticorps pour la prévention et l'inhibition d'infections induites par les staphylocoques | |
DE60041351D1 (de) | Gssytem | |
EP0484403A4 (en) | Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines | |
AU7915391A (en) | In vivo targeting with bifunctional antibodies | |
AU576088B2 (en) | Histamine derivatives, immunogen conjugates and antibodies raised thereto | |
AU4553100A (en) | Tumour-associated antigen | |
EP0801458A3 (fr) | Moteur électrique | |
GB9602878D0 (en) | Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines | |
ZA968988B (en) | Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines | |
HUP0002359A3 (en) | Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide |